No Data
Express News | China International Capital Corporation: The medical instruments Sector is expected to benefit from product upgrades and overseas exports in 2025.
CHUNLI MEDICAL (01858) has appointed Jie Fengbao as the secretary of the Board of Directors.
CHUNLI MEDICAL (01858) announced that the Board of Directors has recently received the submission from the company's Board of Directors Secretary, Ms. Zhang Lili...
chunli medical (688236.SH): accumulated repurchase of 0.226% of shares
On December 2, Gelonhui announced that Chunli Medical (688236.SH) as of November 30, 2024, accumulated repurchased 868,145 shares of the company through the Shanghai Stock Exchange trading system through centralized bidding trading method, accounting for 0.226% of the total share capital of the company. The highest price for the repurchase transaction is 15.96 yuan/share, the lowest price is 12.09 yuan/share, and the total amount paid is RMB 12,018,864.19 (excluding transaction costs).
Chunli Medical (01858) will distribute a cash dividend of 0.0830 yuan per share on November 25.
chunli medical (01858) announced that the company will distribute a cash dividend of 0 per share on November 25, 2024...
Hong Kong stocks anomalies | Medical device stocks rise, medical insurance prepayments expected to accelerate enterprise receivables, innovative devices will usher in a new volume of space.
Most medical instruments stocks are rising. As of the time of publication, Microport (00853) is up 5.01% at 6.92 Hong Kong dollars; Sh Pharma (02607) is up 4.05% at 13.36 Hong Kong dollars; Sinopharm (01099) is up 3.14% at 21.35 Hong Kong dollars.
Chunli Medical (688236) 2024 Third Quarter Report Review: Joint continuation labeling and sports medicine centralized procurement led to performance pressure
Subject: The company released the third quarter report of 24 years, Q1-3 24, operating revenue of 0.508 billion yuan (-35.84%), net income attributable to the parent company of 0.061 billion yuan (-66.14%), net profit after deducting non-recurring gains and losses of 0.044 billion yuan (-7
